Trifluridine/Tipiracil Plus Bevacizumab Improves Survival in Patients With mCRC
Patients with metastatic colorectal cancer who are not eligible for chemotherapy or surgical resection may have a new first-line treatment option.
Source: OncLive
Understanding The Importance Of Financial Habits

